Boston Scientific Corporation (LON:0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
104.56
-0.49 (-0.47%)
At close: Feb 21, 2025
58.02%
Market Cap 121.98B
Revenue (ttm) 13.38B
Net Income (ttm) 1.48B
Shares Out n/a
EPS (ttm) 1.00
PE Ratio 82.41
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,535
Average Volume 43,039
Open 105.91
Previous Close 105.05
Day's Range 104.30 - 105.91
52-Week Range 47.37 - 105.50
Beta 0.81
RSI 62.73
Earnings Date Jan 31, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, c... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 48,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD Financial Statements

News

Boston Scientific announces pricing of €1.5 billion of senior notes

MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V.

1 day ago - PRNewsWire

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.

4 days ago - PRNewsWire

Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

4 days ago - GuruFocus

Sell Alert: EDWARD LUDWIG Cashes Out $1.27M In Boston Scientific Stock

Making a noteworthy insider sell on February 13, EDWARD LUDWIG , Director at Boston Scientific (NYSE: BSX), is reported in the latest SEC filing. What Happened: After conducting a thorough analysis, ...

9 days ago - Benzinga

Boston Scientific Corporation (BSX) Announces Board Member Departure

Boston Scientific Corporation (BSX) Announces Board Member Departure

10 days ago - GuruFocus

What's Behind The 130% Rise In BSX Stock?

Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance, the modest sto...

11 days ago - Forbes

Insider Sell Alert: John Sorenson Sells Shares of Boston Scientific Corp (BSX)

Insider Sell Alert: John Sorenson Sells Shares of Boston Scientific Corp (BSX)

12 days ago - GuruFocus

Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsJonathan Monson - SVP, IRMichael...

17 days ago - Seeking Alpha

Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength

Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.

17 days ago - Investor's Business Daily

Boston Scientific Clocks 22% Jump In Q4 Sales On Strong Heart Devices, Profit And Guidance Exceeds Expectations

On Wednesday, Boston Scientific Corporation (NYSE: BSX) reported fourth-quarter revenues of $4.56 billion, beating the consensus estimate of $4.424 billion . Sales increased 22.4% on a reported basis...

17 days ago - Benzinga

Boston Scientific sees higher-than-expected 2025 profit on strong demand

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

18 days ago - Reuters

Boston Scientific Corp (BSX) Q4 2024 Earnings: Revenue Surpasses Estimates at $4. ...

Boston Scientific Corp (BSX) Q4 2024 Earnings: Revenue Surpasses Estimates at $4.561 Billion, Adjusted EPS Beats at $0.70

18 days ago - GuruFocus

Boston Scientific announces results for fourth quarter and full year 2024

MARLBOROUGH, Mass. , Feb. 5, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024, growing 22.4 percent on a reported ...

18 days ago - PRNewsWire

Earnings Scheduled For February 5, 2025

Companies Reporting Before The Bell • Aurora Cannabis (NASDAQ: ACB) is likely to report quarterly loss at $0.03 per share on revenue of $80.01 million. • LiveWire Gr (NYSE: LVWR) is estimated to rep...

18 days ago - Benzinga

Boston Scientific Q4 2024 Earnings Preview

18 days ago - Seeking Alpha

$1000 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 5 years by 6.26% on an annualized basis producing an average annual return of 19.09%. Currently, Boston Scientific has a market...

24 days ago - Benzinga

Top 4 Health Care Stocks You May Want To Dump In Q1

As of Jan. 21, 2025, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

4 weeks ago - Benzinga

Boston Scientific (BSX) Receives Preliminary Approval for Shareholder Derivative Settlement

Boston Scientific (BSX) Receives Preliminary Approval for Shareholder Derivative Settlement

5 weeks ago - GuruFocus

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation

First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Abl...

5 weeks ago - PRNewsWire

Boston Scientific Jumps Ahead of Earnings

Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.

5 weeks ago - FX Empire

We have the largest venture portfolio in medtech, says Boston Scientific CEO Mike Mahoney

Boston Scientific Chair and CEO Mike Mahoney joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare COnference to talk its outlook for 2025, its venture portfolio, and more.

5 weeks ago - CNBC

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

The Investment Committee discuss some stocks on the move today.

6 weeks ago - CNBC Television

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

The Investment Committee discuss some stocks on the move today.

6 weeks ago - CNBC